ArticleBiomaterials translational2025
Global trends on exosomes in spinal cord injury: A bibliometric analysis and mini-review.
Article in Biomaterials translational, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The miR-212-3p/transferrin axis promotes bone regeneration by modulating iron homeostasis through Schwann cell Exosome-BMSCs communication.Bioactive materials · 2026Article
- Exercise-derived exosomal miR-151-3p: An innovative anti-inflammatory and antioxidant therapeutic for spinal cord injury.Bioactive materials · 2026Article
- The potential mechanisms and regulatory roles of exosomal miRNA in neural repair after spinal cord injury.Frontiers in cellular neuroscience · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI) is recognised as a debilitating condition that often leads to considerable disability and functional limitations. Exosomes, which can be derived from various cell types including bone marrow mesenchymal stem cells, adipose-derived stem cells, dental pulp stem cells, and macrophages, play a pivotal role in the post-SCI landscape. Collectively, it has been observed that these exosomes can modulate the immune response following SCI, regulate the inflammatory environment, inhibit secondary tissue damage, and support neuronal survival and axonal regrowth. However, it is noted that exosomes from different sources exhibit distinct characteristics. Therefore, it is deemed essential to gain a comprehensive understanding of the current knowledge and research directions regarding exosomes in SCI to foster the development of effective therapeutic interventions. In this bibliometric analysis, we conducted to search retrieve pertinent articles from the Web of Science Core Collection and identify pivotal publications, authors, institutions, countries, and keywords that have contributed significantly to the field. This bibliometric analysis offers a thorough examination of the present knowledge landscape and prevailing research trends pertaining to exosomes in the context of SCI. It acts as a valuable asset, catering not only to researchers but also to clinicians and policymakers engaged in research on SCI and therapeutic advancement. Ultimately, this knowledge mapping can advance our understanding of exosome biology and pave the way for innovative interventions to improve outcomes for individuals affected by SCI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.